Literature DB >> 12212782

Nerve growth factor gene therapy for Alzheimer's disease.

Mark H Tuszynski1, Leon Thal, Hoi-Sang U, Mary Margaret Pay, Armin Blesch, James Conner, H Lee Vahlsing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12212782     DOI： 10.1007/s12031-002-0034-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN： 0895-8696            Impact factor:   3.444


× No keyword cloud information.
  5 in total

1.  Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease.

Authors:  Pierre Garcia; Ihsen Youssef; Jo K Utvik; Sabrina Florent-Béchard; Vanassa Barthélémy; Catherine Malaplate-Armand; Badreddine Kriem; Christophe Stenger; Violette Koziel; Jean-Luc Olivier; Marie-Christine Escanye; Marine Hanse; Ahmad Allouche; Cédric Desbène; Frances T Yen; Rolf Bjerkvig; Thierry Oster; Simone P Niclou; Thierry Pillot
Journal:  J Neurosci       Date:  2010-06-02       Impact factor: 6.167

2.  Current experimental therapy for Alzheimer's disease.

Authors:  Sheng Chen; Xiao-Jie Zhang; Liang Li; Wei-Dong Le
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

3.  LLDT-67 attenuates MPTP-induced neurotoxicity in mice by up-regulating NGF expression.

Authors:  Dong-Dong Wu; Li Huang; Lei Zhang; Le-Yu Wu; Yuan-Chao Li; Linyin Feng
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

4.  The brain-tumor related protein podoplanin regulates synaptic plasticity and hippocampus-dependent learning and memory.

Authors:  Ana Cicvaric; Jiaye Yang; Sigurd Krieger; Deeba Khan; Eun-Jung Kim; Manuel Dominguez-Rodriguez; Maureen Cabatic; Barbara Molz; Juan Pablo Acevedo Aguilar; Radoslav Milicevic; Tarik Smani; Johannes M Breuss; Dontscho Kerjaschki; Daniela D Pollak; Pavel Uhrin; Francisco J Monje
Journal:  Ann Med       Date:  2016-08-25       Impact factor: 4.709

Review 5.  Small molecule activators of the Trk receptors for neuroprotection.

Authors:  Nicholas J G Webster; Michael C Pirrung
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.